(19)
(11) EP 3 122 644 A2

(12)

(88) Date of publication A3:
19.11.2015

(43) Date of publication:
01.02.2017 Bulletin 2017/05

(21) Application number: 15711785.4

(22) Date of filing: 25.03.2015
(51) International Patent Classification (IPC): 
B65D 35/10(2006.01)
B65D 35/28(2006.01)
 B65D 35/24(2006.01)
(86) International application number:
PCT/EP2015/056341
(87) International publication number:
WO 2015/144744 (01.10.2015 Gazette 2015/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 27.03.2014 GB 201405509

(71) Applicant: Glaxo Group Limited
Brentford, Middlesex TW8 9GS (GB)

(72) Inventors:
  • BLACHFORD, Marcus
    Warwick Warwickshire CV34 4AB (GB)
  • BLUNDRED, Neil
    Warwick Warwickshire CV34 4AB (GB)
  • CAVE, George
    Warwick Warwickshire CV34 4AB (GB)
  • KAY, Peter
    Warwick Warwickshire CV34 4AB (GB)
  • REGESTER, James
    Warwick Warwickshire CV34 4AB (GB)
  • RITCHIE, Simon
    Weybridge Surrey KT13 0DE (GB)
  • SOUTHERNWOOD, Clive
    Warwick Warwickshire CV34 4AB (GB)

(74) Representative: Povey, Alexander W.G. 
GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) NOVEL DEVICE